Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$91,401,630
-$16,477,717 QoQ
Shares Held
4,672,885
+34.8% QoQ
Ownership
4.53%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 10%
Shared 0%
None 90%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. VRDN ranks #70 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in VRDN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,401,630 | 4,672,885 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $107,879,347 | 3,466,560 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $55,118,902 | 2,554,166 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $35,696,895 | 2,553,426 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $38,626,940 | 2,865,500 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $67,527,590 | 3,522,566 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $54,139,858 | 2,379,774 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $36,068,650 | 2,772,379 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $78,595,648 | 4,488,615 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $58,988,581 | 2,708,383 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $45,125,524 | 2,941,690 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $69,427,998 | 2,918,369 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $61,102,097 | 2,401,812 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $54,423,779 | 1,863,190 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $24,172,039 | 1,178,549 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,265,102 | 455,065 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,220,340 | 66,000 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $672,990 | 34,041 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $392,184 | 23,841 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $201,939 | 11,041 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||